Blocking the interaction between apolipoprotein e and Aβ reduces intraneuronal accumulation of Aβ and inhibits synaptic degeneration

Magdalena A. Kuszczyk, Sandrine Sanchez, Joanna Pankiewicz, Jungsu Kim, Malgorzata Duszczyk, Maitea Guridi, Ayodeji A. Asuni, Patrick M. Sullivan, David M. Holtzman, Martin J. Sadowski

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Accumulation of β-amyloid (Aβ) in the brain is a key event in Alzheimer disease pathogenesis. Apolipoprotein (Apo) E is a lipid carrier protein secreted by astrocytes, which shows inherent affinity for Aβ and has been implicated in the receptor-mediated Aβ uptake by neurons. To characterize ApoE involvement in the intraneuronal Aβ accumulation and to investigate whether blocking the ApoE/Aβ interaction could reduce intraneuronal Aβ buildup, we used a noncontact neuronal-astrocytic co-culture system, where synthetic Aβ peptides were added into the media without or with cotreatment with Aβ12-28P, which is a nontoxic peptide antagonist of ApoE/Aβ binding. Compared with neurons cultured alone, intraneuronal Aβ content was significantly increased in neurons co-cultured with wild-type but not with ApoE knockout (KO) astrocytes. Neurons co-cultured with astrocytes also showed impaired intraneuronal degradation of Aβ, increased level of intraneuronal Aβ oligomers, and marked down-regulation of several synaptic proteins. Aβ12-28P treatment significantly reduced intraneuronal Aβ accumulation, including Aβ oligomer level, and inhibited loss of synaptic proteins. Furthermore, we showed significantly reduced intraneuronal Aβ accumulation in APPSW/PS1 dE9/ApoE KO mice compared with APPSW/PS1 dE9/ApoE targeted replacement mice that expressed various human ApoE isoforms. Data from our co-culture and in vivo experiments indicate an essential role of ApoE in the mechanism of intraneuronal Aβ accumulation and provide evidence that ApoE/Aβ binding antagonists can effectively prevent this process.

Original languageEnglish (US)
Pages (from-to)1750-1768
Number of pages19
JournalAmerican Journal of Pathology
Volume182
Issue number5
DOIs
StatePublished - May 2013
Externally publishedYes

Fingerprint

Apolipoproteins
Apolipoproteins E
Astrocytes
Neurons
compound A 12
Coculture Techniques
Peptides
Amyloid
Knockout Mice
Carrier Proteins
Alzheimer Disease
Protein Isoforms
Proteins
Down-Regulation
Lipids

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Blocking the interaction between apolipoprotein e and Aβ reduces intraneuronal accumulation of Aβ and inhibits synaptic degeneration. / Kuszczyk, Magdalena A.; Sanchez, Sandrine; Pankiewicz, Joanna; Kim, Jungsu; Duszczyk, Malgorzata; Guridi, Maitea; Asuni, Ayodeji A.; Sullivan, Patrick M.; Holtzman, David M.; Sadowski, Martin J.

In: American Journal of Pathology, Vol. 182, No. 5, 05.2013, p. 1750-1768.

Research output: Contribution to journalArticle

Kuszczyk, MA, Sanchez, S, Pankiewicz, J, Kim, J, Duszczyk, M, Guridi, M, Asuni, AA, Sullivan, PM, Holtzman, DM & Sadowski, MJ 2013, 'Blocking the interaction between apolipoprotein e and Aβ reduces intraneuronal accumulation of Aβ and inhibits synaptic degeneration', American Journal of Pathology, vol. 182, no. 5, pp. 1750-1768. https://doi.org/10.1016/j.ajpath.2013.01.034
Kuszczyk, Magdalena A. ; Sanchez, Sandrine ; Pankiewicz, Joanna ; Kim, Jungsu ; Duszczyk, Malgorzata ; Guridi, Maitea ; Asuni, Ayodeji A. ; Sullivan, Patrick M. ; Holtzman, David M. ; Sadowski, Martin J. / Blocking the interaction between apolipoprotein e and Aβ reduces intraneuronal accumulation of Aβ and inhibits synaptic degeneration. In: American Journal of Pathology. 2013 ; Vol. 182, No. 5. pp. 1750-1768.
@article{885ba42194ee4402915bebd8adf8da49,
title = "Blocking the interaction between apolipoprotein e and Aβ reduces intraneuronal accumulation of Aβ and inhibits synaptic degeneration",
abstract = "Accumulation of β-amyloid (Aβ) in the brain is a key event in Alzheimer disease pathogenesis. Apolipoprotein (Apo) E is a lipid carrier protein secreted by astrocytes, which shows inherent affinity for Aβ and has been implicated in the receptor-mediated Aβ uptake by neurons. To characterize ApoE involvement in the intraneuronal Aβ accumulation and to investigate whether blocking the ApoE/Aβ interaction could reduce intraneuronal Aβ buildup, we used a noncontact neuronal-astrocytic co-culture system, where synthetic Aβ peptides were added into the media without or with cotreatment with Aβ12-28P, which is a nontoxic peptide antagonist of ApoE/Aβ binding. Compared with neurons cultured alone, intraneuronal Aβ content was significantly increased in neurons co-cultured with wild-type but not with ApoE knockout (KO) astrocytes. Neurons co-cultured with astrocytes also showed impaired intraneuronal degradation of Aβ, increased level of intraneuronal Aβ oligomers, and marked down-regulation of several synaptic proteins. Aβ12-28P treatment significantly reduced intraneuronal Aβ accumulation, including Aβ oligomer level, and inhibited loss of synaptic proteins. Furthermore, we showed significantly reduced intraneuronal Aβ accumulation in APPSW/PS1 dE9/ApoE KO mice compared with APPSW/PS1 dE9/ApoE targeted replacement mice that expressed various human ApoE isoforms. Data from our co-culture and in vivo experiments indicate an essential role of ApoE in the mechanism of intraneuronal Aβ accumulation and provide evidence that ApoE/Aβ binding antagonists can effectively prevent this process.",
author = "Kuszczyk, {Magdalena A.} and Sandrine Sanchez and Joanna Pankiewicz and Jungsu Kim and Malgorzata Duszczyk and Maitea Guridi and Asuni, {Ayodeji A.} and Sullivan, {Patrick M.} and Holtzman, {David M.} and Sadowski, {Martin J.}",
year = "2013",
month = "5",
doi = "10.1016/j.ajpath.2013.01.034",
language = "English (US)",
volume = "182",
pages = "1750--1768",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Blocking the interaction between apolipoprotein e and Aβ reduces intraneuronal accumulation of Aβ and inhibits synaptic degeneration

AU - Kuszczyk, Magdalena A.

AU - Sanchez, Sandrine

AU - Pankiewicz, Joanna

AU - Kim, Jungsu

AU - Duszczyk, Malgorzata

AU - Guridi, Maitea

AU - Asuni, Ayodeji A.

AU - Sullivan, Patrick M.

AU - Holtzman, David M.

AU - Sadowski, Martin J.

PY - 2013/5

Y1 - 2013/5

N2 - Accumulation of β-amyloid (Aβ) in the brain is a key event in Alzheimer disease pathogenesis. Apolipoprotein (Apo) E is a lipid carrier protein secreted by astrocytes, which shows inherent affinity for Aβ and has been implicated in the receptor-mediated Aβ uptake by neurons. To characterize ApoE involvement in the intraneuronal Aβ accumulation and to investigate whether blocking the ApoE/Aβ interaction could reduce intraneuronal Aβ buildup, we used a noncontact neuronal-astrocytic co-culture system, where synthetic Aβ peptides were added into the media without or with cotreatment with Aβ12-28P, which is a nontoxic peptide antagonist of ApoE/Aβ binding. Compared with neurons cultured alone, intraneuronal Aβ content was significantly increased in neurons co-cultured with wild-type but not with ApoE knockout (KO) astrocytes. Neurons co-cultured with astrocytes also showed impaired intraneuronal degradation of Aβ, increased level of intraneuronal Aβ oligomers, and marked down-regulation of several synaptic proteins. Aβ12-28P treatment significantly reduced intraneuronal Aβ accumulation, including Aβ oligomer level, and inhibited loss of synaptic proteins. Furthermore, we showed significantly reduced intraneuronal Aβ accumulation in APPSW/PS1 dE9/ApoE KO mice compared with APPSW/PS1 dE9/ApoE targeted replacement mice that expressed various human ApoE isoforms. Data from our co-culture and in vivo experiments indicate an essential role of ApoE in the mechanism of intraneuronal Aβ accumulation and provide evidence that ApoE/Aβ binding antagonists can effectively prevent this process.

AB - Accumulation of β-amyloid (Aβ) in the brain is a key event in Alzheimer disease pathogenesis. Apolipoprotein (Apo) E is a lipid carrier protein secreted by astrocytes, which shows inherent affinity for Aβ and has been implicated in the receptor-mediated Aβ uptake by neurons. To characterize ApoE involvement in the intraneuronal Aβ accumulation and to investigate whether blocking the ApoE/Aβ interaction could reduce intraneuronal Aβ buildup, we used a noncontact neuronal-astrocytic co-culture system, where synthetic Aβ peptides were added into the media without or with cotreatment with Aβ12-28P, which is a nontoxic peptide antagonist of ApoE/Aβ binding. Compared with neurons cultured alone, intraneuronal Aβ content was significantly increased in neurons co-cultured with wild-type but not with ApoE knockout (KO) astrocytes. Neurons co-cultured with astrocytes also showed impaired intraneuronal degradation of Aβ, increased level of intraneuronal Aβ oligomers, and marked down-regulation of several synaptic proteins. Aβ12-28P treatment significantly reduced intraneuronal Aβ accumulation, including Aβ oligomer level, and inhibited loss of synaptic proteins. Furthermore, we showed significantly reduced intraneuronal Aβ accumulation in APPSW/PS1 dE9/ApoE KO mice compared with APPSW/PS1 dE9/ApoE targeted replacement mice that expressed various human ApoE isoforms. Data from our co-culture and in vivo experiments indicate an essential role of ApoE in the mechanism of intraneuronal Aβ accumulation and provide evidence that ApoE/Aβ binding antagonists can effectively prevent this process.

UR - http://www.scopus.com/inward/record.url?scp=84876569513&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876569513&partnerID=8YFLogxK

U2 - 10.1016/j.ajpath.2013.01.034

DO - 10.1016/j.ajpath.2013.01.034

M3 - Article

C2 - 23499462

AN - SCOPUS:84876569513

VL - 182

SP - 1750

EP - 1768

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 5

ER -